Mycoprotein, Resistance Training, and Hypertrophy
Launched by UNIVERSITY OF EXETER · Jun 18, 2018
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
Protein is vital for the preservation of health and optimal adaptation to training. However, animal proteins come with a number of economic and environmental issues. Accordingly, the investigators need to develop an evidence base for more sustainable dietary proteins to support human nutrition. Mycoprotein is a non-animal protein produced by the continuous fermentation of the fungus Fusarium Venenatum. Previously, in a mechanistic study, it was determined that a single bolus of mycoprotein effectively supports muscle building in both rested and exercised skeletal muscle, to a similar extent...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Males and females 18 - 40 years of age.
- • Body mass index between 18 and 30.
- • Recreationally active.
- • Resistance training experienced (have previous performed resistance exercise, and are familiar with the basic movements).
- Exclusion Criteria:
- • Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes) (as this may affect normal protein metabolism).
- • Any diagnosed cardiovascular disease or hypertension (to avoid any complications associated with heavy exercise).
- • Elevated blood pressure at the time of screening. (An average systolic blood pressure reading of ≥140mmHg over two or more measurements and an average diastolic blood pressure of ≥90mmHg over two or more measurements.)
- • Chronic use of any prescribed or over the counter pharmaceuticals (that may modulate muscle protein metabolism).
- • A personal or family history of epilepsy, seizures or schizophrenia.
- • Allergic to mycoprotein / Quorn, penicillin, or milk.
- • Pregnancy.
About University Of Exeter
The University of Exeter is a leading research institution in the United Kingdom, renowned for its commitment to advancing knowledge and innovation across various disciplines, including health and medicine. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. The University of Exeter aims to translate scientific findings into practical applications that improve patient outcomes and inform public health strategies, fostering collaboration between researchers, healthcare professionals, and community stakeholders to address critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Exeter, Devon, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials